(BCSF) Bain Capital Specialty - Ratings and Ratios
Credit, Senior, Junior, Equity
BCSF EPS (Earnings per Share)
BCSF Revenue
Description: BCSF Bain Capital Specialty
Bain Capital Specialty Finance Inc (NYSE:BCSF) is a US-based company operating in the Asset Management & Custody Banks sub-industry. As a common stock, BCSFs performance is closely tied to the overall market sentiment and the specific dynamics of the asset management industry.
The companys financial health is reflected in its market capitalization of $976.27M USD, indicating a moderate size that can provide stability while still allowing for growth opportunities. The Price-to-Earnings (P/E) ratio of 9.07 suggests that BCSF is relatively undervalued compared to its earnings, potentially making it an attractive investment. Furthermore, the forward P/E of 10.38 implies expected growth in earnings. The Return on Equity (RoE) of 9.72% indicates a decent return for shareholders, suggesting effective management of equity.
Key Performance Indicators (KPIs) to watch for BCSF include Assets Under Management (AUM), revenue growth, and net interest margin, as these metrics are crucial for asset management companies. Economic drivers such as interest rates, market volatility, and overall economic growth will significantly impact BCSFs performance. For instance, rising interest rates can increase the companys revenue from lending activities, while market downturns can affect AUM and, consequently, management fees.
To further analyze BCSFs potential, its essential to examine its investment portfolio composition, credit quality, and the competitive landscape within the asset management industry. Understanding the companys leverage, liquidity, and regulatory compliance will also provide insights into its operational efficiency and risk management practices.
Investors should monitor BCSFs ability to maintain a stable RoE, grow its AUM, and navigate the competitive asset management landscape. The companys beta of 0.870 indicates relatively lower volatility compared to the broader market, which could be appealing to risk-averse investors. Overall, a comprehensive analysis of BCSFs financials, industry dynamics, and macroeconomic factors will be crucial in determining its investment potential.
BCSF Stock Overview
| Market Cap in USD | 933m |
| Sub-Industry | Asset Management & Custody Banks |
| IPO / Inception | 2018-11-15 |
BCSF Stock Ratings
| Growth Rating | 36.4% |
| Fundamental | 35.2% |
| Dividend Rating | 94.5% |
| Return 12m vs S&P 500 | -20.9% |
| Analyst Rating | 3.67 of 5 |
BCSF Dividends
| Dividend Yield 12m | 12.60% |
| Yield on Cost 5y | 29.90% |
| Annual Growth 5y | 9.64% |
| Payout Consistency | 100.0% |
| Payout Ratio | 89.1% |
BCSF Growth Ratios
| Growth Correlation 3m | -26.7% |
| Growth Correlation 12m | -45% |
| Growth Correlation 5y | 85.4% |
| CAGR 5y | 18.32% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.71 |
| CAGR/Mean DD 3y (Pain Ratio) | 3.29 |
| Sharpe Ratio 12m | -0.19 |
| Alpha | -21.33 |
| Beta | 0.868 |
| Volatility | 20.43% |
| Current Volume | 333.4k |
| Average Volume 20d | 333.4k |
| Stop Loss | 13.6 (-3.2%) |
| Signal | -0.96 |
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (111.1m TTM) > 0 and > 6% of Revenue (6% = 12.5m TTM) |
| FCFTA -0.01 (>2.0%) and ΔFCFTA -10.80pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 47.98% (prev 30.67%; Δ 17.30pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.06 (>3.0%) and CFO -162.5m <= Net Income 111.1m (YES >=105%, WARN >=100%) |
| Net Debt (-164.8m) to EBITDA (51.7m) ratio: -3.19 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.98 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (64.9m) change vs 12m ago 0.47% (target <= -2.0% for YES) |
| Gross Margin 75.20% (prev 91.58%; Δ -16.38pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 8.04% (prev 9.97%; Δ -1.94pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.64 (EBITDA TTM 51.7m / Interest Expense TTM 79.7m) >= 6 (WARN >= 3) |
Altman Z'' 0.32
| (A) 0.04 = (Total Current Assets 202.3m - Total Current Liabilities 102.2m) / Total Assets 2.77b |
| (B) -0.01 = Retained Earnings (Balance) -25.1m / Total Assets 2.77b |
| (C) 0.02 = EBIT TTM 51.2m / Avg Total Assets 2.59b |
| (D) -0.02 = Book Value of Equity -25.0m / Total Liabilities 1.64b |
| Total Rating: 0.32 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 35.17
| 1. Piotroski 2.50pt = -2.50 |
| 2. FCF Yield -1.19% = -0.60 |
| 3. FCF Margin -12.99% = -4.87 |
| 4. Debt/Equity 1.32 = 1.68 |
| 5. Debt/Ebitda 29.16 = -2.50 |
| 6. ROIC - WACC (= -2.46)% = -3.08 |
| 7. RoE 9.72% = 0.81 |
| 8. Rev. Trend -22.67% = -1.70 |
| 9. EPS Trend -41.54% = -2.08 |
What is the price of BCSF shares?
Over the past week, the price has changed by -0.99%, over one month by -7.59%, over three months by -3.79% and over the past year by -5.61%.
Is Bain Capital Specialty a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BCSF is around 16.52 USD . This means that BCSF is currently undervalued and has a potential upside of +17.58% (Margin of Safety).
Is BCSF a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BCSF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16.2 | 15.1% |
| Analysts Target Price | 16.2 | 15.1% |
| ValueRay Target Price | 17.7 | 26.3% |
Last update: 2025-10-02 02:25
BCSF Fundamental Data Overview
CCE Cash And Equivalents = 164.8m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 8.689
P/E Forward = 10.3842
P/S = 3.2882
P/B = 0.8189
P/EG = 1.0697
Beta = 0.868
Revenue TTM = 208.5m USD
EBIT TTM = 51.2m USD
EBITDA TTM = 51.7m USD
Long Term Debt = 1.41b USD (from nonCurrentLiabilitiesTotal, last fiscal year)
Short Term Debt = 102.2m USD (from totalCurrentLiabilities, last fiscal year)
Debt = 1.51b USD (Calculated: Short Term 102.2m + Long Term 1.41b)
Net Debt = -164.8m USD (from netDebt column, last quarter)
Enterprise Value = 2.28b USD (932.8m + Debt 1.51b - CCE 164.8m)
Interest Coverage Ratio = 0.64 (Ebit TTM 51.2m / Interest Expense TTM 79.7m)
FCF Yield = -1.19% (FCF TTM -27.1m / Enterprise Value 2.28b)
FCF Margin = -12.99% (FCF TTM -27.1m / Revenue TTM 208.5m)
Net Margin = 53.26% (Net Income TTM 111.1m / Revenue TTM 208.5m)
Gross Margin = 75.20% ((Revenue TTM 208.5m - Cost of Revenue TTM 51.7m) / Revenue TTM)
Tobins Q-Ratio = -90.99 (set to none) (Enterprise Value 2.28b / Book Value Of Equity -25.0m)
Interest Expense / Debt = 1.44% (Interest Expense 21.8m / Debt 1.51b)
Taxrate = 3.61% (4.47m / 123.9m)
NOPAT = 49.3m (EBIT 51.2m * (1 - 3.61%))
Current Ratio = 1.98 (Total Current Assets 202.3m / Total Current Liabilities 102.2m)
Debt / Equity = 1.32 (Debt 1.51b / last Quarter total Stockholder Equity 1.14b)
Debt / EBITDA = 29.16 (Net Debt -164.8m / EBITDA 51.7m)
Debt / FCF = -55.63 (Debt 1.51b / FCF TTM -27.1m)
Total Stockholder Equity = 1.14b (last 4 quarters mean)
RoA = 4.00% (Net Income 111.1m, Total Assets 2.77b )
RoE = 9.72% (Net Income TTM 111.1m / Total Stockholder Equity 1.14b)
RoCE = 2.01% (Ebit 51.2m / (Equity 1.14b + L.T.Debt 1.41b))
RoIC = 1.92% (NOPAT 49.3m / Invested Capital 2.57b)
WACC = 4.38% (E(932.8m)/V(2.44b) * Re(9.21%)) + (D(1.51b)/V(2.44b) * Rd(1.44%) * (1-Tc(0.04)))
Shares Correlation 3-Years: 81.65 | Cagr: 0.24%
Discount Rate = 9.21% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -27.1m)
EPS Correlation: -41.54 | EPS CAGR: -53.44% | SUE: -5.0 | # QB: 0
Revenue Correlation: -22.67 | Revenue CAGR: 15.68% | SUE: 0.10 | # QB: 0
Additional Sources for BCSF Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle